Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-horizant-22399-gabapentin-enacarbil-for-extended-release-tablets-300-mg-and-600-mg-1560927506.pdf

29 Apr 2019

http://www.reuters.com/article/2015/10/01/us-xenoport-ceo-idUSKCN0RV5V920151001

Rosmi Shaji REUTERS
01 Oct 2015